HRT Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-29,231
| Closed | -$64K | – | 2705 |
|
2025
Q1 | $64K | Buy |
+29,231
| New | +$64K | ﹤0.01% | 1980 |
|
2024
Q4 | – | Sell |
-426,817
| Closed | -$849K | – | 2522 |
|
2024
Q3 | $849K | Buy |
+426,817
| New | +$849K | ﹤0.01% | 1228 |
|
2024
Q1 | – | Sell |
-199,908
| Closed | -$339K | – | 2486 |
|
2023
Q4 | $339K | Buy |
+199,908
| New | +$339K | ﹤0.01% | 1431 |
|
2023
Q2 | – | Sell |
-547,365
| Closed | -$826K | – | 2594 |
|
2023
Q1 | $826K | Buy |
547,365
+107,981
| +25% | +$163K | 0.01% | 985 |
|
2022
Q4 | $1.1M | Buy |
439,384
+58,943
| +15% | +$147K | 0.02% | 842 |
|
2022
Q3 | $1.61M | Buy |
+380,441
| New | +$1.61M | 0.02% | 665 |
|
2022
Q1 | – | Sell |
-37,662
| Closed | -$343K | – | 3111 |
|
2021
Q4 | $343K | Buy |
+37,662
| New | +$343K | ﹤0.01% | 1940 |
|